Skip to main content
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.


Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Revised Statement on Evusheld

The Panel now recommends against the use of tixagevimab plus cilgavimab for pre-exposure prophylaxis (PrEP) of COVID-19.

Antivirals, Including Antibody Products

These sections summarize the data on antiviral agents, including remdesivir, ritonavir-boosted nirmatrelvir, and anti-SARS-CoV-2 monoclonal antibodies.


These sections summarize the data on IL-6 inhibitors, kinase inhibitors, and other immunomodulators.

Antithrombotic Therapy

This section discusses screening, prevention, and treatment for thromboembolism in people with COVID-19.

Miscellaneous Drugs

These sections summarize the data on metformin, colchicine, fluvoxamine, and other miscellaneous drugs.


These sections discuss the rationale for using supplements in people with COVID-19.

Concomitant Medications

Review the data on using certain concomitant therapies in people with COVID-19.